tiprankstipranks
Atossa Therapeutics (ATOS)
NASDAQ:ATOS
US Market
ATOS
Atossa Therapeutics
RESEARCH TOOLSreports
Want to see ATOS full AI Analyst Report?

Atossa Therapeutics (ATOS) Income Statement

2,567 Followers

Atossa Therapeutics Income Statement

Last quarter (Q4 2025), Atossa Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Atossa Therapeutics's net income was $-10.94M. See Atossa Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Mar 24Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -16.00K$ -17.00K$ -23.00K$ -8.00K$ -23.00K
Operating Expenses
$ 37.14M$ 27.62M$ 31.38M$ 27.69M$ 20.52M
Depreciation and Amortization
$ 16.00K$ 17.00K$ 23.00K$ 8.00K$ 23.00K
EBITDA
$ -37.13M$ -27.60M$ -31.35M$ -27.68M$ -20.50M
Operating Income
$ -37.14M$ -27.62M$ -31.38M$ -27.69M$ -20.52M
Other Income/Expenses
$ 2.37M$ 2.12M$ 1.28M$ 731.00K$ -85.00K
Pretax Income
$ -34.77M$ -25.50M$ -30.09M$ -26.96M$ -20.61M
Net Income
$ -34.77M$ -25.50M$ -30.09M$ -26.96M$ -20.61M
Per Share Metrics
Basic EPS
$ -4.04$ -3.00$ -3.60$ -3.15$ -2.70
Diluted EPS
$ -4.04$ -3.00$ -3.60$ -3.15$ -2.70
Weighted Average Shares Outstanding
 8.61M 8.39M 8.41M 8.44M 7.80M
Weighted Average Shares Outstanding (Diluted)
 8.61M 8.39M 8.41M 8.44M 7.80M
Currency in USD

Atossa Therapeutics Earnings and Revenue History